Bowel cancer survival statistics

Survival

Survive bowel cancer for 10 or more years, 2010-11, England and Wales

Age

Age that bowel cancer survival is highest, 2009-2013, England

 

Improvement

Bowel cancer survival in the UK has more than doubled in the last 40 years

 

77% of men survive bowel cancer for at least one year, and this is predicted to fall to 59% surviving for five years or more, as shown by age-standardised Open a glossary item  net survival for patients diagnosed with bowel cancer during 2010-2011 in England and Wales.[1] Survival for women at one and five years is slightly lower, with 74% surviving for one year or more, and 58% predicted to survive for at least five years.

Bowel Cancer (C18-C20 and C21.8), Age-Standardised One-, Five- and Ten-Year Net Survival, Adults (Aged 15-99), England and Wales, 2010-2011

1-Year Survival (%) 5-Year Survival (%) 10-Year Survival (%)
Men Net Survival 77.4 59.2 56.0
95% LCL 77.4 59.2 55.9
95% UCL 77.4 59.4 56.2
Women Net Survival 73.9 58.2 57.2
95% LCL 73.9 58.0 57.0
95% UCL 73.9 58.3 57.4
Adults Net Survival 75.7 58.7 56.6
95% LCL 75.7 58.6 56.4
95% UCL 75.7 58.8 56.7

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item.

Survival is a weighted average derived from data for colon (C18) and rectum cancer (C19-C20, C21.8)

Five- and ten-year survival is predicted using an excess hazard statistical model

Bowel cancer survival falls only slightly beyond five years after diagnosis, which means most patients can be considered cured after five years. 56% of men and 57% of women are predicted to survive their disease for ten years or more, as shown by age-standardised net survival for patients diagnosed with bowel cancer during 2010-2011 in England and Wales.[1] Out of 20 common cancers in England and Wales, ten-year survival for bowel cancer ranks 10th highest overall.

Bowel Cancer (C18-C20 and C21.8), Net Survival up to Ten Years after Diagnosis, Adults (Aged 15-99), England and Wales, 2010-2011

Survival is a weighted average derived from data for colon (C18) and rectum cancer (C19-C20, C21.8)

Survival for bowel cancer is reported in Scotland and Northern Ireland,[2,3] though it is difficult to make survival comparisons between countries due to different methodologies and criteria for including patients in analyses.

References

  1. Data were providede by London School of Hygiene and Tropical Medicine on request, 2014. 
  2. ISD Scotland. Trends in Cancer Survival 1983-2007
  3. Northern Ireland Cancer Registry. Incidence & Survival 1993-2012.

About this data

Data is for England and Wales, 2010-2011, ICD-10 C18-C20 and C21.8

Last reviewed:

Five-year survival for bowel cancer shows an unusual pattern with age: survival overall decreases with increasing age, though in women aged 50-59 and men and women aged 60-69, there is a slight increase compared with the preceding age group. Five-year net survival in men ranges from 69% in 15-39 year-olds to 46% in 80-99 year-olds for patients diagnosed with bowel cancer in England during 2009-2013.[1] In women, five-year survival ranges from 71% to 42% in the same age groups. The slightly higher survival in 60-69 year-olds is likely to be associated with bowel cancer screening in this age group.

Bowel Cancer (C18-C20 and C21.8), Five-Year Net Survival by Age, England, 2009-2013

References

  1. Office for National Statistics. Cancer survival in England: adults diagnosed in 2009 to 2013, followed up to 2014. Newport: ONS; 2015.

About this data

Data is for England, 2009-2013, ICD-10 C18-C20 and C21.8

Last reviewed:

As with most cancers, survival for bowel cancer is improving. One-year age-standardised Open a glossary item net survival for bowel cancer in men has increased from 47% during 1971-1972 to 77% during 2010-2011 in England and Wales – an absolute survival difference Open a glossary item of 30 percentage points.[1] In women, one-year survival has increased from 45% to 74% over the same time period (a difference of 29 percentage points).

Bowel Cancer (C18-C20 and C21.8), Age-Standardised One-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

Survival is a weighted average derived from data for colon (C18) and rectum cancer (C19-C20, C21.8)

Five-year age-standardised Open a glossary item net survival for bowel cancer in men has increased from 25% during 1971-1972 to a predicted survival of 59% during 2010-2011 in England and Wales – an absolute survival difference of 35 percentage points.[1] In women, five-year survival has increased from 24% to 58% over the same time period (a difference of 34 percentage points).

Bowel Cancer (C18-C20 and C21.8), Age-Standardised Five-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

Survival is a weighted average derived from data for colon (C18) and rectum cancer (C19-C20, C21.8).

Five-year survival for 2010-2011 is predicted using an excess hazard statistical model.

Ten-year survival has followed the same trend as one- and five-year survival since the early 1970s. Ten-year age-standardised Open a glossary item net survival for bowel cancer in men has increased from 22% during 1971-1972 to a predicted survival of 56% during 2010-2011 in England and Wales – an absolute survival difference of 35 percentage points.[1] In women, ten-year survival has increased from 22% to 57% over the same time period (a difference of 35 percentage points). Overall, nearly 6 in 10 people diagnosed with bowel cancer today are predicted to survive their disease for at least ten years.

Bowel Cancer (C18-C20 and C21.8), Age-Standardised Ten-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

Survival is a weighted average derived from data for colon (C18) and rectum cancer (C19-C20, C21.8).

Ten-year survival for 2005-2006 and 2010-2011 is predicted using an excess hazard statistical model.

References

  1. Data were provided by London School of Hygiene and Tropical  Medicine on request, 2014.

About this data

Data is for England and Wales, 1971-2011, ICD-10 C18-C20 and C21.8

Last reviewed:

Survival for bowel cancer is strongly related to stage of the disease at diagnosis.

One-year net survival for bowel cancer is highest for patients diagnosed at stage I, and lowest for those diagnosed at stage IV, 2014 data for England show.[1] 98% of patients diagnosed at stage I survived their disease for at least one year, versus 40% of patients diagnosed at stage IV.[1

One-year relative survival for unknown stage bowel cancer is 54%. Lack of staging information may in some cases reflect advanced stage at diagnosis: for example very unwell patients may not undergo staging tests if the invasiveness of the testing outweighs the potential benefit of obtaining stage information.[1]

Bowel Cancer (C18-C20), One-Year One-Year Age Standardised Net Survival by Stage, Adults (Ages 15-99 Years), England 2014

For patients diagnosed at stage IV, one-year net survival is significantly higher for males than for females, with an absolute survival difference of 8 percentage points. One-year survival is similar between the sexes at all other stages.[1]

For patients diagnosed at stage II or stage IV, one-year relative survival is significantly higher among patients in the most deprived areas versus those in the least deprived areas, with absolute survival differences of 4 and 8 percentage points respectively, 2012 data for England show. One-year survival is similar between deprivation groups at all other stages.[2]

Five-year survival for bowel cancer shows a much more rapid decrease in survival between Stages I and IV. In men, five-year relative survival ranges from 95% at Stage I to 7% at Stage IV for patients diagnosed during 2002-2006 in the former Anglia Cancer Network.[3] In women, five-year survival ranges from 100% at Stage I to 8% at Stage IV. There are no significant differences in five-year survival between men and women at any of the stages.

Bowel Cancer (C18-C20), Five-Year Relative Survival by Stage, Adults (Aged 15-99 Years), Former Anglia Cancer Network, 2002-2006

References

  1. Office for National Statistics, Cancer survival by stage at diagnosis for England, 2016.
  2. National Cancer Intelligence Network. Stage Breakdown by CCG 2013. London: NCIN; 2015.
  3. Data were provided by The National Cancer Registration Service, Eastern Office on request. Similar data can be found here: http://www.ncras.nhs.uk/ncrs-east/

About this data

Data is for: England, 2014 (one-year), Former Anglia Cancer Network, 2002-2006 (five-year), ICD-10 C18-C20

Survival statistics give an overall picture of survival and the survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics.

Last reviewed:

There is also an advantage of between 5% and 9% in five-year relative survival for the most affluent patients compared with the most deprived groups.[1]

Last reviewed:

Colon cancer survival in the UK compared to Europe

Five-year relative survival for colon cancer in men in England (51%) is below the average for Europe (56%). Wales (50%) and Scotland (54%) are also below the European average but Northern Ireland (53%) is similar to the European average.[1] Across the European countries for which data is available, five-year relative survival in men ranges from 43% (Latvia) to 61% (Germany).[1]

Five-year relative survival for colon cancer in women in England (52%) is below the average for Europe (56%). Wales (50%) and Scotland (54%) are also below the European average but Northern Ireland (55%) is similar to the European average.[1] Across the European countries for which data is available, five-year relative survival in women ranges from 43% (Latvia) to 65% (Iceland).[1]

Colon Cancer (C18), Age-Standardised Five-Year Relative Survival, Adults (Aged 15+), European Countries, 2000-2007

Data consists of both observed and predicted 5-year relative survival. Where sufficient follow-up was not available for recently diagnosed patients the period approach was used to predict 5-year cohort survival.

Possible explanations for persistent international differences in survival include differences in cancer biology, use of diagnostic tests and screening, stage at diagnosis, access to high-quality care, and data collection practices.[1]

Rectal cancer survival in the UK compared to Europe

Five-year relative survival for rectal cancer in men in England (53%) is below the average for Europe (55%). Wales (49%) is also below the European average but Scotland (53%) and Northern Ireland (52%) are similar to the European average.[1] Across the European countries for which data is available, five-year relative survival in men ranges from 37% (Latvia) to 78% (Iceland).[1]

Five-year relative survival for rectal cancer in women in England (56%) is below the average for Europe (58%). Wales (57%), Scotland (56%) and Northern Ireland (58%) are similar to the European average.[1] Across the European countries for which data is available, five-year relative survival in women ranges from 36% (Latvia) to 67% (Iceland).[1]

Rectal Cancer (C19, C20, C21), Age-Standardised Five-Year Relative Survival, Adults (Aged 15+), European Countries, 2000-2007

Data consists of both observed and predicted 5-year relative survival. Where sufficient follow-up was not available for recently diagnosed patients the period approach was used to predict 5-year cohort survival.

Possible explanations for persistent international differences in survival include differences in cancer biology, use of diagnostic tests and screening, stage at diagnosis, access to high-quality care, and data collection practices.[1]

References

  1. De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol 2014;15:23-34

About this data

Data is for: 29 European countries, patients diagnosed in 2000-2007 and followed up to 2008, colon and rectal cancer (International Classification of Diseases for Oncology [ICD-O-3] C19, C20, C21).

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

Rate this page:

Currently rated: 3.2 out of 5 based on 26 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page